natural killer cell therapy (Enzo)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namenatural killer cell therapy (Enzo)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionNatural killer cells modulators
TargetsUpdating
Therapy Area/IndicationsGraft vs Host DiseaseDiabetes MellitusInflammatory Bowel Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEnzo Biochem Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnzo Biochem Inc
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseaseDiabetes MellitusInflammatory Bowel Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A